1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19

6. Medical Affairs Outsourcing Market, by Services
6.1. Introduction
6.2. Clinical Trial Applications and Product Registrations
6.3. Regulatory Consulting and Legal Representation
6.4. Regulatory Writing and Publishing

7. Medical Affairs Outsourcing Market, by End User
7.1. Introduction
7.2. Biotechnology Companies
7.3. Mid- Sized Pharmaceutical Companies
7.4. Others

8. California Medical Affairs Outsourcing Market

9. Florida Medical Affairs Outsourcing Market

10. Illinois Medical Affairs Outsourcing Market

11. New York Medical Affairs Outsourcing Market

12. Ohio Medical Affairs Outsourcing Market

13. Pennsylvania Medical Affairs Outsourcing Market

14. Texas Medical Affairs Outsourcing Market

15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion

16. Company Usability Profiles
16.1. Accell Clinical Research
16.2. Charles River Laboratories International, Inc.
16.3. Clinilabs, Inc.
16.4. Covance, Inc.
16.5. Criterium, Inc.
16.6. Genpact Ltd
16.7. ICON plc
16.8. Medpace, Inc.
16.9. PARAXEL International Corporation
16.10. Pharmaceutical Product Development, LLC
16.11. PRA Health Sciences, Inc.
16.12. Promedica International
16.13. Quintiles Transnational Corporation
16.14. WuXi AppTec Group

17. Appendix
17.1. Discussion Guide
17.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET: MARKET DYNAMICS
FIGURE 3. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2020 VS 2027 (%)
FIGURE 4. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2027
FIGURE 6. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL TRIAL APPLICATIONS AND PRODUCT REGISTRATIONS, 2018-2027 (USD MILLION)
FIGURE 7. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL TRIAL APPLICATIONS AND PRODUCT REGISTRATIONS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 8. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY CONSULTING AND LEGAL REPRESENTATION, 2018-2027 (USD MILLION)
FIGURE 9. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY CONSULTING AND LEGAL REPRESENTATION, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY WRITING AND PUBLISHING, 2018-2027 (USD MILLION)
FIGURE 11. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY WRITING AND PUBLISHING, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 12. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2020 VS 2027 (%)
FIGURE 13. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2020 VS 2027 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2027
FIGURE 15. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2027 (USD MILLION)
FIGURE 16. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 17. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MID- SIZED PHARMACEUTICAL COMPANIES, 2018-2027 (USD MILLION)
FIGURE 18. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MID- SIZED PHARMACEUTICAL COMPANIES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 19. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OTHERS, 2018-2027 (USD MILLION)
FIGURE 20. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OTHERS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 21. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET: FPNV POSITIONING MATRIX
FIGURE 22. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 23. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL TRIAL APPLICATIONS AND PRODUCT REGISTRATIONS, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY CONSULTING AND LEGAL REPRESENTATION, BY STATE, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY WRITING AND PUBLISHING, BY STATE, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY STATE, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MID- SIZED PHARMACEUTICAL COMPANIES, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OTHERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET: SCORES
TABLE 12. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET: BUSINESS STRATEGY
TABLE 13. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET: PRODUCT SATISFACTION
TABLE 14. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET: RANKING
TABLE 15. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 16. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET: MERGER & ACQUISITION
TABLE 17. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 18. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 19. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET: INVESTMENT & FUNDING
TABLE 20. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 21. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET: LICENSE & PRICING

Companies Mentioned

Accell Clinical Research
Charles River Laboratories International, Inc.
Clinilabs, Inc.
Covance, Inc.
Criterium, Inc.
Genpact Ltd
ICON plc
Medpace, Inc.
PARAXEL International Corporation
Pharmaceutical Product Development, LLC
PRA Health Sciences, Inc.
Promedica International
Quintiles Transnational Corporation
WuXi AppTec Group